Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule-Reference-Cited by-同舟云学术

Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule

Published:2018-11 Issue:6 Volume:8 Page:404-413
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Samson Pamela,Rehman Sana,Juloori Aditya,DeWees Todd,Roach Michael,Bradley Jeffrey,Videtic Gregory M.M.,Stephans Kevin,Robinson Clifford

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference31 articles.

1. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline;Videtic;Pract Radiat Oncol,2017

2. Outcomes in elderly stage I non-small cell lung cancer in the SBRT era: A SEER analysis;Dalwadi,2017

3. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009

4. Cone-beam computed tomographic image guidance for lung cancer radiation therapy;Bissonnette;Int J Radiat Oncol Biol Phys,2009

5. Comparison of helical, maximum intensity projection (MIP), and averaged intensity (AI) 4D CT imaging for stereotactic body radiation therapy (SBRT) planning in lung cancer;Bradley;Radiother Oncol,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consecutive Daily vs. Every Other Day SBRT Scheduling for Stage I NSCLC;Advances in Radiation Oncology;2024-09

2. Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma;Radiotherapy and Oncology;2024-06

3. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-09

4. A competing risk analysis of the patterns and risk factors of recurrence in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy;Radiotherapy and Oncology;2023-08

5. Association of sarcopenia and expression of interleukin-23 in colorectal cancer survival;Clinical Nutrition;2021-10